About Sensible Bio
Sensible Bio is a private company based in Oxford, Oxfordshire, United Kingdom, incorporated in 2021 in Delaware. It has reported $15,347,941 raised in two offerings on Form D since February 2023. Its chief executive is Miroslav Gasparek.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Sep 2, 2026 | $13,518,941of $15.0M target | 15 | $901K | EquityRule 506(b) | Form D ↗ |
| Feb 6, 2023 | Feb 21, 2023 | $1,829,000of $3.0M target | 18 | $101K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $15,347,941 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Sensible Bio's Form D filed Sep 2, 2026.

Marian Kupculak
CSO, Co-Founder and director
On every Form D that Sensible Bio has filed: 2 filings, from Feb 21, 2023 to Sep 2, 2026.

Miroslav Gasparek
CEO, Co-Founder and director
On every Form D that Sensible Bio has filed: 2 filings, from Feb 21, 2023 to Sep 2, 2026.

Joel Schoppig
Partner, Oxford Science Enterprises and director
First appears on the Form D that Sensible Bio filed on September 2, 2026; on 1 of its 2 filings.

Vishal Gulati
Founder and Managing Partner, Recode Ventures, director
First appears on the Form D that Sensible Bio filed on September 2, 2026; on 1 of its 2 filings.
